SAM
Senzar Asset Management Portfolio holdings
AUM
$34.7M
This Quarter Return
+7.91%
1 Year Return
+0.55%
3 Year Return
-0.75%
5 Year Return
–
10 Year Return
–
AUM
$262M
AUM Growth
+$262M
(+39%)
Cap. Flow
+$56.6M
Cap. Flow
% of AUM
21.61%
Top 10 Holdings %
Top 10 Hldgs %
65.28%
Holding
27
New
9
Increased
11
Reduced
6
Closed
1
Top Buys
| 1 |
Insmed
INSM
|
$16.4M |
| 2 |
QCOR
QUESTCOR PHARMA INC
QCOR
|
$14.6M |
| 3 |
Viatris
VTRS
|
$9.83M |
| 4 |
Medtronic
MDT
|
$9.38M |
| 5 |
GSK
GSK
|
$8.62M |
Top Sells
| 1 |
AbbVie
ABBV
|
$9.26M |
| 2 |
AGN
ALLERGAN INC
AGN
|
$8.11M |
| 3 |
MDVN
MEDIVATION, INC.
MDVN
|
$6.49M |
| 4 |
Biogen
BIIB
|
$5.57M |
| 5 |
Orthofix Medical
OFIX
|
$3.92M |
Sector Composition
| 1 | Healthcare | 81.45% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Teva Pharmaceuticals
TEVA
$21.1B
| $25.7M | 9.83% |
490,996
+50,596
| +11% | +$2.65M |
|
2
Sanofi
SNY
$121B
| $25.4M | 9.72% |
478,600
+26,000
| +6% | +$1.38M |
|
3
Community Health Systems
CYH
$387M
| $19.1M | 7.3% |
421,400
+25,000
| +6% | +$1.13M |
|
|
4
AbbVie
ABBV
$372B
| $17.5M | 6.67% |
309,595
-164,105
| -35% | -$9.26M |
|
|
5
Insmed
INSM
$28.8B
| $16.4M | 6.25% |
+818,700
| New | +$16.4M |
|
|
QCOR
6
DELISTED
QUESTCOR PHARMA INC
QCOR
| $14.6M | 5.59% |
+158,100
| New | +$14.6M |
|
|
7
Orthofix Medical
OFIX
$592M
| $14.2M | 5.41% |
390,898
-108,200
| -22% | -$3.92M |
|
8
Amgen
AMGN
$155B
| $14.1M | 5.39% |
119,298
-8,800
| -7% | -$1.04M |
|
|
MDVN
9
DELISTED
MEDIVATION, INC.
MDVN
| $12.9M | 4.91% |
166,834
-84,266
| -34% | -$6.49M |
|
10
Enanta Pharmaceuticals
ENTA
$180M
| $11M | 4.2% |
255,128
+114,000
| +81% | +$4.91M |
|
|
11
Viatris
VTRS
$12.3B
| $9.83M | 3.76% |
+190,700
| New | +$9.83M |
|
|
12
Medtronic
MDT
$119B
| $9.38M | 3.58% |
+147,100
| New | +$9.38M |
|
|
AGN
13
DELISTED
ALLERGAN INC
AGN
| $8.78M | 3.35% |
51,900
-47,900
| -48% | -$8.11M |
|
|
14
GSK
GSK
$79.9B
| $8.62M | 3.29% |
+161,100
| New | +$8.62M |
|
|
MGLN
15
DELISTED
Magellan Health Services, Inc.
MGLN
| $6.74M | 2.57% |
108,200
+4,800
| +5% | +$299K |
|
16
Cardinal Health
CAH
$35.5B
| $6.56M | 2.51% |
95,700
+6,600
| +7% | +$453K |
|
|
WCG
17
DELISTED
Wellcare Health Plans, Inc.
WCG
| $5.91M | 2.26% |
79,100
-10,000
| -11% | -$747K |
|
|
XNPT
18
DELISTED
XENOPORT, INC.
XNPT
| $5.66M | 2.16% |
1,172,700
+385,100
| +49% | +$1.86M |
|
|
KYTH
19
DELISTED
KYTHERA BIOPHARMACEUTICALS, INC COM
KYTH
| $4.79M | 1.83% |
124,900
+35,400
| +40% | +$1.36M |
|
|
SGNT
20
DELISTED
SAGENT PHARMACEUTICALS INC COM STK (DE)
SGNT
| $4.74M | 1.81% |
183,100
+47,700
| +35% | +$1.23M |
|
|
MNTA
21
DELISTED
Momenta Pharmaceuticals, Inc.
MNTA
| $4.65M | 1.78% |
+384,900
| New | +$4.65M |
|
|
FPRX
22
DELISTED
Five Prime Therapeutics, Inc.
FPRX
| $4.07M | 1.56% |
262,000
+213,300
| +438% | +$3.32M |
|
|
CORI
23
DELISTED
Corium International, Inc.
CORI
| $3.98M | 1.52% |
+511,500
| New | +$3.98M |
|
24
Rigel Pharmaceuticals
RIGL
$697M
| $3.35M | 1.28% |
923,200
+501,800
| +119% | +$1.82M |
|
25
Talphera
TLPH
$11.1M
| $2.01M | 0.77% |
+195,600
| New | +$2.01M |
|